In this issue: Communication in the era of 'personalized' medicine

Annals of Family Medicine

Volumn 4, Issue 3, 2006, Pages 194-196

  Stange, Kurt C ^a   Acheson, Louise S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR CHANGE; CARDIOVASCULAR RISK; CESAREAN SECTION; CHILDBIRTH; DOCTOR PATIENT RELATION; EDITORIAL; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; INTERPERSONAL COMMUNICATION; ISCHEMIC HEART DISEASE; MALPRACTICE; MEDICAL LITERATURE; MEDICAL PRACTICE; MEDICAL RESEARCH; PATIENT ATTITUDE; PATIENT CARE; PHYSICIAN ATTITUDE; PRIMARY MEDICAL CARE; RISK FACTOR; RISK REDUCTION;

EID: 33744755064     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.589     Document Type: Editorial

References (35)

1. Stange KC, Miller WL, McLellan LA, et al. Annals Journal Club: it's time to get RADICAL. Ann Fam Med. 2006;4:196-197.
2. Annals Journal Club: A RADICAL approach. Ann Fam Med. 2006;4:iii.
3. Frich JC, Ose L, Malterud K, Fugelli P. Perceived vulnerability to heart disease in patients with familial hypercholesterolemia: a qualitative interview study. Ann Fam Med. 2006;4:198-204.
4. Goldman RE, Parker D, Eaton C, et al. Patients' perceptions of cholesterol, cardiovascular disease risk, and risk communication strategies. Ann Fam Med. 2006;4:205-212.
5. Snyderman R, Langheier J. Prospective health care: the second transformation of medicine. Genome Biol. 2006;7:104.
6. Lunshof JE, Pirmohamed M, Gurwitz D. Personalized medicine: decades away? Pharmacogenomics. 2006;7:237-241.
7. Ferrara J. Personalized medicine: challenges in assessing and capturing value in the commercial environment. Expert Rev Mol Diagn. 2006;6:129-131.
8. Svinte M. The promise of personalized medicine: a conversation with Michael Svinte. Interview by Michael Millenson. Health Aff (Millwood). 2006;25:w54-60.
9. Kalow W. Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine. Pharmacogenomics J. 2006;
10. Ginsburg GS, McCarthy JJ. Personalized medicine: revolutionizing drug discovery and patient care. Trends Biotechnol. 2001;19:491-496.
11. Liotta LA, Kohn EC, Petricoin EF. Clinical proteomics: personalized molecular medicine. JAMA. 2001;286:2211-2214.
12. Langreth R, Waldholz M. New era of personalized medicine: targeting drugs for each unique genetic profile. Oncologist. 1999;4:426-427.
13. Snyderman R, Langheier J. Prospective health care: the second transformation of medicine. Genome Biol. 2006;7:104. Epub 2006 Feb 27.
14. Langreth R, Waldholz M. New era of personalized medicine: targeting drugs for each unique genetic profile. Oncologist. 1999;4:426-7.
15. Williams EC, Kivlahan D, Saitz R, et al. Readiness to change in primary care patients who screened positive for alcohol misuse. Ann Fam Med. 2006;4:213-220.
16. Helton MR, van der Steen JT, Daaleman TP, Gamble G, Ribbe M. A cross-cultural study of physician treatment decisions for demented nursing home patients who develop pneumonia. Ann Fam Med. 2006;4:221-227.
17. Gordon PR. Thoughts on communication. Ann Fam Med. 2006;4:264-265.
18. Zweifler JA, Garza A, Hughes S, Stanich M, Hierholzer A, Lau M. Vaginal birth after cesarean in California: before and after a change in guidelines. Ann Fam Med. 2006;4:228-234.
19. Leeman LM, Plante L. Patient choice vaginal delivery? Ann Fam Med. 2006;4:265-268.
20. Thomas P, Graffy J, Wallace P, Kirby M. How can primary care networks help integrate academic and service initiatives in primary care? Ann Fam Med. 2006;4:235-239.
21. Guirguis-Blake JM, Fryer GE, Phillips RL, Szabat R, Green LA. The US medical liability system: evidence for legislative reform. Ann Fam Med. 2006;4:240-246.
22. Gartlehner G, Hansen R, Carson S, Lohr K. The efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes. Ann Fam Med. 2006;4:253-262.
23. Mainous AG III, Smith D, Geesey ME, Tilley B. Development of a measure to assess patient trust in medical researchers. Ann Fam Med. 2006;4:247-252.
24. Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academy Press; 2000.
25. Gamble VN. A legacy of distrust: African Americans and medical research. Am J Prev Med. 1993;9:35-38.
26. Freimuth VS, Quinn SC, Thomas SB, et al. African Americans' views on research and the Tuskegee Syphilis Study. Soc Sci Med. 2001;52:797-808.
27. Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med. 1999;14:537-546.
28. Petersen LA. Racial differences in trust: reaping what we have sown? Med Care. 2002;40:81-84.
29. Boulware LE, Cooper LA, Ratner LE, LaVeist TA, Powe NR. Race and trust in the health care system. Public Health Rep. 2003;118:358-365.
30. Shavers VL, Lynch CF, Burmeister LF. Factors that influence African-Americans' willingness to participate in medical research studies. Cancer. 2001;91:233-236.
31. Shavers VL, Lynch CF, Burmeister LF. Racial differences in factors that influence the willingness to participate in medical research studies. Ann Epidemiol. 2002;12:248-256.
32. Byrd WM, Clayton LA. An American health dilemma: a history of blacks in the health system. J Natl Med Assoc. 1992;84:189-200.
33. Goodson MG. Enslaved Africans and doctors in South Carolina. J Natl Med Assoc. 2003;95:225-233.
34. Cooper LA, Hill MN, Powe NR. Designing and evaluating interventions to eliminate racial and ethnic disparities in health care. J Gen Intern Med. 2002;17:477-486.
35. Gamble VN. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health. 1997;87:1773-1778.